• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LKB1 信号通路与肝癌患者的生存预后。

LKB1 signaling and patient survival outcomes in hepatocellular carcinoma.

机构信息

Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.

Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA.

出版信息

Pharmacol Res. 2023 Jun;192:106757. doi: 10.1016/j.phrs.2023.106757. Epub 2023 Apr 5.

DOI:10.1016/j.phrs.2023.106757
PMID:37023992
Abstract

The liver is a major organ that is involved in essential biological functions such as digestion, nutrient storage, and detoxification. Furthermore, it is one of the most metabolically active organs with active roles in regulating carbohydrate, protein, and lipid metabolism. Hepatocellular carcinoma is a cancer of the liver that is associated in settings of chronic inflammation such as viral hepatitis, repeated toxin exposure, and fatty liver disease. Furthermore, liver cancer is the most common cause of death associated with cirrhosis and is the 3rd leading cause of global cancer deaths. LKB1 signaling has been demonstrated to play a role in regulating cellular metabolism under normal and nutrient deficient conditions. Furthermore, LKB1 signaling has been found to be involved in many cancers with most reports identifying LKB1 to have a tumor suppressive role. In this review, we use the KMPlotter database to correlate RNA levels of LKB1 signaling genes and hepatocellular carcinoma patient survival outcomes with the hopes of identifying potential biomarkers clinical usage. Based on our results STRADß, CAB39L, AMPKα, MARK2, SIK1, SIK2, BRSK1, BRSK2, and SNRK expression has a statistically significant impact on patient survival.

摘要

肝脏是一个重要的器官,参与许多重要的生理功能,如消化、营养物质储存和解毒。此外,肝脏是新陈代谢最活跃的器官之一,在调节碳水化合物、蛋白质和脂质代谢方面发挥着积极的作用。肝细胞癌是一种与慢性炎症相关的肝癌,如病毒性肝炎、反复毒素暴露和脂肪肝疾病。此外,肝癌是与肝硬化相关的最常见的死亡原因,也是全球癌症死亡的第 3 大主要原因。研究表明 LKB1 信号在正常和营养缺乏条件下调节细胞代谢中发挥作用。此外,LKB1 信号还参与多种癌症,大多数报告表明 LKB1 具有肿瘤抑制作用。在这篇综述中,我们使用 KMPlotter 数据库来关联 LKB1 信号基因的 RNA 水平和肝细胞癌患者的生存结果,希望能确定潜在的临床应用生物标志物。根据我们的结果,STRADß、CAB39L、AMPKα、MARK2、SIK1、SIK2、BRSK1、BRSK2 和 SNRK 的表达对患者的生存有统计学意义上的影响。

相似文献

1
LKB1 signaling and patient survival outcomes in hepatocellular carcinoma.LKB1 信号通路与肝癌患者的生存预后。
Pharmacol Res. 2023 Jun;192:106757. doi: 10.1016/j.phrs.2023.106757. Epub 2023 Apr 5.
2
AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.作为细胞生理学和癌症中LKB1下游靶点的AMPKα样蛋白
J Mol Med (Berl). 2021 May;99(5):651-662. doi: 10.1007/s00109-021-02040-y. Epub 2021 Mar 4.
3
Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.Naa20,NatB 复合物的催化亚基,通过调节 LKB1-AMPK-mTOR 轴促进肝细胞癌的发生。
Exp Mol Med. 2020 Nov;52(11):1831-1844. doi: 10.1038/s12276-020-00525-3. Epub 2020 Nov 20.
4
C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.LKB1的C末端磷酸化对于AMP活化蛋白激酶、BRSK1、BRSK2的调节或细胞周期停滞并非必需。
J Biol Chem. 2009 Jan 2;284(1):77-84. doi: 10.1074/jbc.M806152200. Epub 2008 Oct 14.
5
Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment.评估肝脏激酶B1下游信号在各种乳腺癌中的表达及全身化疗后的无复发生存情况。
Oncotarget. 2021 May 25;12(11):1110-1115. doi: 10.18632/oncotarget.27929.
6
HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.HDAC11 通过 LKB1/AMPK 信号通路调控糖酵解以维持肝癌干细胞干性。
Cancer Res. 2021 Apr 15;81(8):2015-2028. doi: 10.1158/0008-5472.CAN-20-3044. Epub 2021 Feb 18.
7
Hepatitis B virus X protein represses LKB1 expression to promote tumor progression and poor postoperative outcome in hepatocellular carcinoma.乙型肝炎病毒 X 蛋白抑制 LKB1 的表达,促进肝癌的肿瘤进展和术后不良预后。
Surgery. 2018 May;163(5):1040-1046. doi: 10.1016/j.surg.2017.11.030. Epub 2018 Feb 21.
8
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.LKB1是一种主要激酶,可激活AMPK亚家族的13种激酶,包括MARK/PAR-1。
EMBO J. 2004 Feb 25;23(4):833-43. doi: 10.1038/sj.emboj.7600110. Epub 2004 Feb 19.
9
Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.非酒精性脂肪性肝炎相关肝细胞癌的增殖过程中,LKB1-Akt 信号通路的激活不依赖于磷酸肌醇 3-激酶,这一过程发挥着关键性作用。
Hepatology. 2010 Nov;52(5):1621-31. doi: 10.1002/hep.23860.
10
PIM kinases inhibit AMPK activation and promote tumorigenicity by phosphorylating LKB1.PIM 激酶通过磷酸化 LKB1 抑制 AMPK 的激活并促进肿瘤发生。
Cell Commun Signal. 2021 Jun 30;19(1):68. doi: 10.1186/s12964-021-00749-4.

引用本文的文献

1
Deciphering the roles of neddylation modification in hepatocellular carcinoma: Molecular mechanisms and targeted therapeutics.解读NEDDylation修饰在肝细胞癌中的作用:分子机制与靶向治疗
Genes Dis. 2024 Dec 6;12(4):101483. doi: 10.1016/j.gendis.2024.101483. eCollection 2025 Jul.
2
Role of SIK1 in tumors: Emerging players and therapeutic potentials (Review).SIK1 在肿瘤中的作用:新兴的参与者和治疗潜力(综述)。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8828. Epub 2024 Oct 18.
3
Discovery of the Natural Bibenzyl Compound Erianin in Dendrobium Inhibiting the Growth and EMT of Gastric Cancer through Downregulating the LKB1-SIK2/3-PARD3 Pathway.
发现铁皮石斛中二苄基化合物艾里安灵通过下调 LKB1-SIK2/3-PARD3 通路抑制胃癌的生长和 EMT。
Int J Mol Sci. 2024 Jul 21;25(14):7973. doi: 10.3390/ijms25147973.
4
TNIK in disease: from molecular insights to therapeutic prospects.TNIK 在疾病中的作用:从分子机制到治疗前景。
Apoptosis. 2024 Oct;29(9-10):1361-1376. doi: 10.1007/s10495-024-01987-w. Epub 2024 Jun 9.
5
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of mA-modified PTEN mRNA in pancreatic ductal adenocarcinoma.Hsa_circ_0007590/PTBP1复合物通过降低胰腺导管腺癌中mA修饰的PTEN mRNA的稳定性来重编程葡萄糖代谢。
Cancer Gene Ther. 2024 Jul;31(7):1090-1102. doi: 10.1038/s41417-024-00786-4. Epub 2024 May 27.